Financhill
Back

United Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing slight buying pressure.

United Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 357.28 Buy
20-day SMA: 350.45 Buy
50-day SMA: 342.47 Buy
200-day SMA: 274.68 Buy
8-day EMA: 356.22 Buy
20-day EMA: 351.97 Buy
50-day EMA: 340.94 Buy
200-day EMA: 291.94 Buy

United Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.6 Buy
Relative Strength Index (14 RSI): 60.27 Buy
Chaikin Money Flow: 81908 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (344.92 - 358.62) Buy
Bollinger Bands (100): (289.16 - 349.34) Buy

United Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for United Therapeutics Stock

Is United Therapeutics Stock a Buy?

UTHR Technical Analysis vs Fundamental Analysis

Buy
51
United Therapeutics (UTHR) is a Buy

Is United Therapeutics a Buy or a Sell?

United Therapeutics Stock Info

Market Cap:
15.92B
Price in USD:
357.83
Share Volume:
201.12K

United Therapeutics 52-Week Range

52-Week High:
366.08
52-Week Low:
208.62
Buy
51
United Therapeutics (UTHR) is a Buy

United Therapeutics Share Price Forecast

Is United Therapeutics Stock a Buy?

  • United Therapeutics share price is 357.83 while UTHR 8-day exponential moving average is 356.22, which is a Buy signal.
  • The stock price of UTHR is 357.83 while United Therapeutics 20-day EMA is 351.97, which makes it a Buy.
  • United Therapeutics 50-day exponential moving average is 340.94 while UTHR share price is 357.83, making it a Buy technically.
  • UTHR stock price is 357.83 and United Therapeutics 200-day simple moving average is 291.94, creating a Buy signal.

Fundamental Analysis of United Therapeutics

Is United Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.68 per share, and an increase next year of $1.77 per share.

Technical Analysis of United Therapeutics

Should I short United Therapeutics stock?

* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.